Lung metastases from cutaneous adenoid cystic carcinoma 23 years after initial treatment

Naoko Arano; Yoshiteru Morio; Toshiro Futagawa; Akane Hashizume; Osamu Nagashima; Shin-Ichi Sasaki; Shigeru Tominaga; Kazuhisa Takahashi

doi:10.1016/j.rmcr.2017.04.015

Lung metastases from cutaneous adenoid cystic carcinoma 23 years after initial treatment

Respir Med Case Rep. 2017 Apr 19:21:121-123. doi: 10.1016/j.rmcr.2017.04.015. eCollection 2017.

Authors

Naoko Arano¹, Yoshiteru Morio¹, Toshiro Futagawa², Akane Hashizume³, Osamu Nagashima¹, Shin-Ichi Sasaki¹, Shigeru Tominaga¹, Kazuhisa Takahashi⁴

Affiliations

¹ Department of Respiratory Medicine, Juntendo University Urayasu Hospital, 2-1-1 Tomioka, Urayasu-shi, Chiba, 279-0021, Japan.
² Department of General Thoracic Surgery, Juntendo University Urayasu Hospital, 2-1-1 Tomioka, Urayasu-shi, Chiba, 279-0021, Japan.
³ Department of Diagnostic Pathology, Juntendo University Urayasu Hospital, 2-1-1 Tomioka, Urayasu-shi, Chiba, 279-0021, Japan.
⁴ Department of Respiratory Medicine, Juntendo University Graduate School of Medicine, 3-1-3 Hongo, Bunkyo-Ku, Tokyo, 113-8431, Japan.

Abstract

Cutaneous adenoid cystic carcinoma (CACC) is an extremely rare neoplasm of head and neck region, and is characterized by propensity for local recurrence and perineural invasion. Late distant metastases occur usually to lungs. Although patients with lung metastases from CACC cannot be cured, long-term survival may be possible due to its slow-growing malignancy. We report a case of a 69-year-old female with lung metastases from CACC 23 years after initial surgery of scalp nodule.

Keywords: Cutaneous adenoid cystic carcinoma; Lung metastases; Thyroid transcription factor 1.

Publication types

Case Reports